Abstract
This study was designed to assess the effect of honey supplementation and sugar-based hypercaloric regimen on weight gain and blood pressure (BP) in Wistar rats. Animals were fed for 8 weeks with standard diet (S-free) or a hypercaloric diet (standard chow and 30% sugar in drinking water), (SF), or standard chow supplemented with fat and honey and 10% sugar in drinking water (HF). Overall weight gain and body fat levels were significantly higher in SF and HF than in S-free. Fat cells were significantly larger in SF compared with HF. Compared with SF and S-free, HF had higher glucose, but triglycerides, and LDLc levels were not different. BP was significantly higher in SF but not in HF compared to S-free. These observations indicate that honey may afford a protection against increase in BP and in fat cell size resulting from a hypercaloric diet.
Keywords: Carbohydrate, Honey, Hypertension, Obesity, Rats, Fat cell size, weight gain, blood pressure, SF, HF, overweight, glucose, sucrose, fructose, metabolic syndrome, adipose tissue, dyslipidemia, cytokine, Diet, LDLc, enzymatic colorimetric kit, Histology, Tuckey test, Body Weight, adipocyte size, Plasma Glucose, Triglycerides, hypercaloric diet, metabolism, hypertrophy, hyperplasia
Letters in Drug Design & Discovery
Title: Effects of Honey Against the Accumulation of Adipose Tissue and the Increased Blood Pressure on Carbohydrate-Induced Obesity in Rat
Volume: 8 Issue: 1
Author(s): Samanta Romero-Silva, Miguel Angel Martinez R, Laura P. Romero-Romero, Oralia Rodriguez, C. Gerardo Salas G, Nicole Morel, Francisco Javier Lopez-Munoz, Luis Angel Lima-Mendoza and Guadalupe Bravo
Affiliation:
Keywords: Carbohydrate, Honey, Hypertension, Obesity, Rats, Fat cell size, weight gain, blood pressure, SF, HF, overweight, glucose, sucrose, fructose, metabolic syndrome, adipose tissue, dyslipidemia, cytokine, Diet, LDLc, enzymatic colorimetric kit, Histology, Tuckey test, Body Weight, adipocyte size, Plasma Glucose, Triglycerides, hypercaloric diet, metabolism, hypertrophy, hyperplasia
Abstract: This study was designed to assess the effect of honey supplementation and sugar-based hypercaloric regimen on weight gain and blood pressure (BP) in Wistar rats. Animals were fed for 8 weeks with standard diet (S-free) or a hypercaloric diet (standard chow and 30% sugar in drinking water), (SF), or standard chow supplemented with fat and honey and 10% sugar in drinking water (HF). Overall weight gain and body fat levels were significantly higher in SF and HF than in S-free. Fat cells were significantly larger in SF compared with HF. Compared with SF and S-free, HF had higher glucose, but triglycerides, and LDLc levels were not different. BP was significantly higher in SF but not in HF compared to S-free. These observations indicate that honey may afford a protection against increase in BP and in fat cell size resulting from a hypercaloric diet.
Export Options
About this article
Cite this article as:
Romero-Silva Samanta, Angel Martinez R Miguel, P. Romero-Romero Laura, Rodriguez Oralia, Gerardo Salas G C., Morel Nicole, Javier Lopez-Munoz Francisco, Angel Lima-Mendoza Luis and Bravo Guadalupe, Effects of Honey Against the Accumulation of Adipose Tissue and the Increased Blood Pressure on Carbohydrate-Induced Obesity in Rat, Letters in Drug Design & Discovery 2011; 8 (1) . https://dx.doi.org/10.2174/157018011793663912
DOI https://dx.doi.org/10.2174/157018011793663912 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fetal Mechanisms That Lead to Later Hypertension
Current Drug Targets Evidence-Based Percutaneous Closure of the Left Atrial Appendage in Patients with Atrial Fibrillation
Current Cardiology Reviews Diagnostic use of Adenosine for Atrial Flutter with Regular Tachycardia
New Emirates Medical Journal Saving the Ischemic Penumbra: Potential Role for Statins and Phosphodiesterase Inhibitors
Current Vascular Pharmacology Regulation of Blood Pressure by D5 Dopamine Receptors
Cardiovascular & Hematological Agents in Medicinal Chemistry Cytoprotection by Inhaled Carbon Monoxide before Cardiopulmonary Bypass in Preclinical Models
Current Pharmaceutical Biotechnology Emerging Therapeutic Potential of Whey Proteins and Peptides
Current Pharmaceutical Design Atenolol: Differences in Mode of Action Compared with other Antihypertensives.An Opportunity to Identify Features that Influence Outcome?
Current Pharmaceutical Design Novel Biomarkers Assessing the Calcium Deposition in Coronary Artery Disease
Current Medicinal Chemistry Complementary Role of Herbal Medicine and Exercise in Cardiovascular Disease Prevention and Management: A Review of Evidence
Current Pharmaceutical Design Statins Influence Long Term Restenosis and Cardiovascular Events Following Carotid Endarterectomy
Current Vascular Pharmacology Role of Mechanical Stress in Monocytes / Macrophages: Implications for Atherosclerosis
Current Vascular Pharmacology The Many Antithrombotic Actions of Nitric Oxide
Current Drug Targets Cross Talk Among Leukocytes, Platelets, and Endothelial Cells and its Relevance to Atherosclerosis and Coronary Heart Disease
Current Nutrition & Food Science From Raynaud’s Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach
Current Rheumatology Reviews An Update on Peptide Drugs for Voltage-Gated Calcium Channels
Recent Patents on CNS Drug Discovery (Discontinued) Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets Metabolic and Cardiovascular Complications of Highly Active Antiretroviral Therapy for HIV Infection
Current HIV Research Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?
Current Vascular Pharmacology Therapeutic Indications and Action Mechanisms of Bilirubin: Suggestions from Natural Calculus Bovis
Current Signal Transduction Therapy